The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis (Q35824886)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 October 2015

Language	Label	Description	Also known as
English	The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis	scientific article published on 29 October 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

based on heuristic

inferred from title

Clostridium butyricum

object named as

Clostridium butyricum

1 reference

based on heuristic

inferred from title

author name string

Asuka Yasueda

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Tsunekazu Mizushima

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Riichiro Nezu

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Ryoko Sumi

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Mamoru Tanaka

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Junichi Nishimura

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Yasuyuki Kai

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Masaki Hirota

8

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Hideki Osawa

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Kiyokazu Nakajima

10

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Masaki Mori

11

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Toshinori Ito

12

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

publication date

29 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

939-949

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Guidelines for the management of inflammatory bowel disease in adults

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Laparoscopic surgery for ulcerative colitis: a review of the literature.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Chronic pouchitis after ileal pouch-anal anastomosis for ulcerative colitis: effect on quality of life

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Treatment strategy for preventing pouchitis as a postoperative complication of ulcerative colitis: the significance of the management of cuffitis

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Intestinal microbiota and secretory immunoglobulin A in feces of exclusively breast-fed infants with blood-streaked stools

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Catabolism of glucose and lactose in Bifidobacterium animalis subsp. lactis, studied by 13C Nuclear Magnetic Resonance

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Clostridium butyricum MIYAIRI 588 improves high-fat diet-induced non-alcoholic fatty liver disease in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Proctocolectomy and ileostomy to pouch surgery for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Possible role of Escherichia coli in propagation and perpetuation of chronic inflammation in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Production of 1,3-propanediol by Clostridium butyricum VPI 3266 using a synthetic medium and raw glycerol.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Enteric microbiota leads to new therapeutic strategies for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

The transcription factor PU.1 is involved in macrophage proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Clostridium butyricum TO-A culture supernatant downregulates TLR4 in human colonic epithelial cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1261-9

21 January 2018

Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26510664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/26510664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26510664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Membrane peroxidation by lipopolysaccharide and iron-ascorbate adversely affects Caco-2 cell function: beneficial role of butyric acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/26510664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical features and management of pouchitis in Japanese ulcerative colitis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26510664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Butyrate-enhanced TNFalpha-induced apoptosis is associated with inhibition of NF-kappaB.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26510664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MIF regulates innate immune responses through modulation of Toll-like receptor 4

1 reference

https://pubmed.ncbi.nlm.nih.gov/26510664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Probiotics in chronic pouchitis: restoring luminal microbial balance

1 reference

https://pubmed.ncbi.nlm.nih.gov/26510664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00595-015-1261-9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35824886&oldid=1667247684"